Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

BACKGROUND: Antibodies inhibiting the programmed death receptor 1 (PD-1) have shown significant activity in the treatment of advanced cutaneous melanoma. The efficacy and safety of PD-1 blockade in patients with uveal melanoma has not been well characterized. METHODS: 58 stage IV uveal melanoma pati...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer
Hoofdauteurs: Algazi, Alain P., Tsai, Katy K., Shoushtari, Alexander N., Munhoz, Rodrigo R., Eroglu, Zeynep, Piulats, Josep M, Ott, Patrick A., Johnson, Douglas B., Hwang, Jimmy, Daud, Adil I., Sosman, Jeffrey, Carvajal, Richard D., Chmielowski, Bartosz, Postow, Michael A., Weber, Jeffrey S., Sullivan, Ryan J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5767160/
https://ncbi.nlm.nih.gov/pubmed/27533448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30258
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items